Receptor-mediated gene delivery with non-viral DNA carriers

Journal of Liposome Research

Volumn 10, Issue 4, 2000, Pages 443-460

  Kichler, A ^a   Frisch, B ^a   De Souza, D L ^a   Schuber, F ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Folate; Gal GalNAc; Gene transfer; Receptor mediated endocytosis; RGD

Indexed keywords

CARRIER PROTEIN; DRUG CARRIER; FOLIC ACID; INTEGRIN RECEPTOR; LIGAND; N ACETYLGALACTOSAMINE; NUCLEIC ACID;

BINDING AFFINITY; CONFERENCE PAPER; CONJUGATION; DNA BINDING; DNA PROTEIN COMPLEX; DRUG DELIVERY SYSTEM; ENDOCYTOSIS; GENE TARGETING; GENETIC TRANSFECTION; HALF LIFE TIME; HUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN DNA INTERACTION; REACTION ANALYSIS; TARGET CELL;

EID: 0034523863     PISSN: 08982104     EISSN: None     Source Type: Journal    
DOI: 10.3109/08982100009031110     Document Type: Conference Paper

References (77)

1. Condensation of vector DNA by the chromosomal protein HMG1 results in efficient transfection
2. Ligand-polylysine mediated gene transfer
3. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine
4. Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure
5. Efficient gene transfer into mammalian primary endocrine cells with lipopolyamine-coated DNA
6. Improvements in cationic liposomes for in vivo gene transfer
7. Synthesis and characterization of a tri-galactosylated bisacridine compound to target DNA to hepatocytes
8. Application of membrane-active peptides for drug and gene delivery across cellular membranes
9. Transferrin-polycation-mediated introduction of DNA into human leukemic cells: Stimulation by agents that affect the survival of transfected DNA or modulate transferrin receptor levels
10. Putative role of chloroquine in gene transfer into a human hepatoma cell line by DNA/lactosylated polylysine complexes
11. Glycerol enhancement of ligand-polylysine/DNA transfection
12. Glycerol and polylysine synergize in their ability to rupture vesicular membranes: A mechanism for increased transferrin-polylysine-mediated gene transfer
13. Evidence for targeted gene delivery to HepG2 hepatoma cells in vitro
14. Liver-directed gene delivery
15. Gene transfer into hepatocytes using asialoglycoprotein receptor mediated endocytosis of DNA complexed with an artificial tetra-antennary galactose ligand
16. Specific gene transfer mediated by lactosylated poly-L-lysine into hepatoma cells
17. Targeted gene transfer into hepatoma cells with lipopolyamine-condensed DNA particles presenting galactose ligands: A stage toward artificial viruses
18. Receptor-mediated endocytosis and nuclear transport of a transfecting DNA construct
19. Delivery of drugs, proteins and genes into cells using transferrin as a ligand for receptor-mediated endocytosis
20. Gene transfer by DNA/glycosylated polylysine complexes into human blood monocyte-derived macrophages
21. Receptor-mediated gene transfer into macrophages
22. A novel gene delivery system using EGF receptor-mediated endocytosis
23. Targeting of a cholecystokinin-DNA complex to pancreatic cells in vitro and in vivo
24. Folate receptor mediated DNA delivery into tumor cells: Potosomal disruption results in enhanced gene expression
25. Gene transfer with synthetic virus-like particles via the integrin-mediated endocytosis pathway
26. An RGD-oligolysine peptide: A prototype construct for integrin-mediated gene delivery
27. Receptor-mediated gene transfer into human T lymphocytes via binding of DNA/CD3 antibody particles to the CD3 T cell receptor complex
28. Gene transfer into the airway epithelium of animals by targeting the polymeric immunoglobulin receptor
29. Use of N-terminal modified poly(L-lysine)-antibody conjugate as a carrier for targeted gene delivery in mouse lung endothelial cells
30. Targeted gene delivery to alveolar macrophages via Fc receptor-mediated endocytosis
31. Gene transfer into hepatoma cell lines via the serpin enzyme complex receptor
32. Gene transfer mediated by alpha2-macroglobulin
33. Identification of receptor ligands with phage display peptide libraries
34. Toward cell-targeting gene therapy vectors: Selection of cell-binding peptides from random peptide-presenting phage libraries
35. Organ targeting in vivo using phage display peptide libraries
36. Scanning whole cells with phage-display libraries: Identification of peptide ligands that modulate cell function
37. Novel peptides selected to bind vascular endothelial growth factor target the receptor-binding site
38. In vitro gene delivery to hepatocytes with galactosylated polyethylenimine
39. Preparation of asialoorosomucoid-polylysine conjugates
40. Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery
41. Glycosylated polylysine/DNA complexes: Gene transfer efficiency in relation with the size and the sugar substitution level of glycosylated polylysines and with the plasmid size
42. Transfection and physical properties of various saccharide, poly(ethylene glycol), and antibody-derivatized polyethylenimines (PEI)
43. Carbohydrate-mediated liposomal targeting and drug delivery
44. Receptor mediated glycotargeting
45. Ligand structural requirements for recognition and binding by the hepatic asialoglycoprotein receptor
46. New synthetic cluster ligands for galactose/N-acetylgalactosamine-specific lectin of mammalian liver
47. Binding modes of mammalian hepatic Gal/GalNAc receptors
48. Synthetic oligosaccharides in glycobiology - An overview
49. Binding of synthetic oligosaccharides to the hepatic Gal/GalNAc lectin. Dependence on fine structural features
50. The galactose-recognizing system of rat peritoneal macrophages; identification and characterization of the receptor molecule
51. Galactose-specific receptors on liver cells. I. Hepatocyte and liver macrophage receptors differ in their membrane anchorage
52. Lactose-poly(ethylene glycol)-grafted poly-L-lysine as hepatoma cell-targeted gene carrier
53. Receptor-mediated in vitro gene transformation by a soluble DNA carrier system
54. Targeting of genes to the liver with glycoprotein carriers
55. Receptor-mediated delivery of foreign genes to hepatocytes
56. An evaluation of receptor-mediated gene transfer using synthetic DNA-ligand complexes
57. Fate of DNA targeted to the liver by asialoglycoprotein receptor-mediated endocytosis in vivo. Prolonged persistence in cytoplasmic vesicles after partial hepatectomy
58. Gene transfer in vivo: Sustained expression and regulation of genes introduced into the liver by receptor-targeted uptake
59. Versatile synthesis of bi- and tri-antennary galactose ligands: Interaction with the Gal/GalNAc receptor of human hepatoma cells
60. Influence of the galactosyl ligand structure on the interaction of galactosylated liposomes with mouse peritoneal macrophages
61. Comparative affinity of synthetic multi-antennary galactosyl derivatives for the Gal/GalNAc receptor of rat hepatocytes and peritoneal macrophages
62. The differences in structural specificity for recognition and binding between asialoglycoprotein receptors of liver and macrophages
63. Integrins: Versality, modulation, and signalling in cell adhesion
64. Integrin-mediated transfection with peptides containing arginine-glycine-aspartic acid domains
65. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model
66. Folate-mediated targeting of therapeutic and imaging agents to cancers
67. Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis
68. Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro
69. Targeting folate receptor with folate linked to extremities of poly(Ethylene glycol)-grafted liposomes: In vitro studies
70. Folate-targeted, anionic liposome-entrapped polylysine-condensed DNA for tumor cell-specific gene transfer
71. An update on non-clathrin-coated endocytosis
72. Targeted, non-viral gene delivery for cancer gene therapy
73. Polylysine-based transfection systems utilizing receptor-mediated delivery
74. Receptor-mediated delivery of plasmid DNA
75. Nonviral vectors for in vivo gene delivery: Physicochemical and pharmacokinetic considerations
76. Effects of membrane-active agents in gene delivery
77. Nuclear transport of exogenous DNA